| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/31/2005 | US20050069577 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies |
| 03/31/2005 | US20050069548 Uses of agents that bind immune system components |
| 03/31/2005 | US20050069543 Antibody mixture; immunosuppressant ; antitumor agents |
| 03/31/2005 | US20050069535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 03/31/2005 | CA2539306A1 Haloalkyl containing compounds as cysteine protease inhibitors |
| 03/31/2005 | CA2539172A1 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 03/31/2005 | CA2539061A1 Use of an antagonist of il-6 for treating il-6-mediated diseases |
| 03/31/2005 | CA2538760A1 Human .beta.-defensin secretion promoter |
| 03/31/2005 | CA2538284A1 Modulators of p-selectin glycoprotein ligand 1 |
| 03/31/2005 | CA2537731A1 Compositions useful as inhibitors of protein kinases |
| 03/31/2005 | CA2534959A1 Antibodies with altered effector functions |
| 03/30/2005 | EP1518932A1 Modified vaccinia virus Ankara (MVA) mutant and use thereof |
| 03/30/2005 | EP1518864A2 Antibody against rhesus D |
| 03/30/2005 | EP1518557A1 Anti-hiv agent |
| 03/30/2005 | EP1517914A2 9-alpha-substituted estratrienes as selectively active estrogen |
| 03/30/2005 | EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/30/2005 | EP1517905A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 03/30/2005 | EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 03/30/2005 | EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 03/30/2005 | EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 03/30/2005 | EP1436007B1 Compounds for use as surfactants |
| 03/30/2005 | EP1395226A4 Use of radiopharmaceutical complexes in achieving transplantation tolerance |
| 03/30/2005 | EP1360184B1 Piperidine derivatives as neurokinin 1 antagonists |
| 03/30/2005 | EP1250133B1 Ophthalmic anti-allergy compositions suitable for use with contact lenses |
| 03/30/2005 | EP1216299B1 Gene transfer in human lymphocytes using retroviral scfv cell targeting vectors |
| 03/30/2005 | EP1181035B1 Substantially oil-free cyclosporin compositions |
| 03/30/2005 | EP1135414B1 Allo and auto-reactive t-cell epitopes |
| 03/30/2005 | EP1105378B1 Quinazoline derivatives |
| 03/30/2005 | EP1091942B1 Potassium channel blocking agents |
| 03/30/2005 | EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders |
| 03/30/2005 | EP0791056B1 Lipid-cleavage enzyme complex |
| 03/30/2005 | CN1602425A Therapeutic and diagnostic uses of antibody specificity profiles |
| 03/30/2005 | CN1602358A Recombinant fusion proteins and the trimers thereof |
| 03/30/2005 | CN1602292A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 03/30/2005 | CN1602200A Plant extract active as an immunostimulating agent |
| 03/30/2005 | CN1602199A Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/30/2005 | CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 03/30/2005 | CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution |
| 03/30/2005 | CN1600304A Application of extractive of ussurian grape on curing inflammatory disease |
| 03/30/2005 | CN1600297A Loratadine paster of penetrating skin |
| 03/30/2005 | CN1194985C Diterpene compound of veronicastrum sibiricum and its extraction separation method |
| 03/30/2005 | CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments |
| 03/30/2005 | CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 03/30/2005 | CN1194743C Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof |
| 03/30/2005 | CN1194690C Composition for treating bronchial asthma and allergic rhinitis |
| 03/30/2005 | CN1194679C External Tranilast lipid gel prepn and its prepn process |
| 03/30/2005 | CN1194668C Application of nano copper powder in preparation of immunopotentiator medicine |
| 03/29/2005 | US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/29/2005 | US6872735 LFA-1 antagonist compounds |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione |
| 03/29/2005 | US6872719 Antiinflammatory agents; autoimmune disease |
| 03/29/2005 | US6872528 Cell culture; for use as tool in gene therapy and cel packaging |
| 03/29/2005 | CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/29/2005 | CA2335186C Pyrrolo[2,3-d]pyrimidine compounds |
| 03/29/2005 | CA2301732C Therapeutic combinations |
| 03/29/2005 | CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/29/2005 | CA1341477C Method of reducing immunoglobulin e responses |
| 03/24/2005 | WO2005026210A2 Therapeutic binding molecules |
| 03/24/2005 | WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR |
| 03/24/2005 | WO2005026113A1 1, 3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 03/24/2005 | WO2005025608A1 Ifn-ϝ for treatment of diseases associated with malfunction of the nod2 gene |
| 03/24/2005 | WO2005025607A1 Methods of stimulating innate immunity using cationic peptides |
| 03/24/2005 | WO2005025604A2 Use of hmgb and hmgb fragments to decrease specific immune response |
| 03/24/2005 | WO2005025597A1 Peptides that promote complement activation |
| 03/24/2005 | WO2005025586A1 Cytokine modulators and related method of use |
| 03/24/2005 | WO2005000348A3 Vaccines inducing nkt-cell and toll-like-receptor activation |
| 03/24/2005 | WO2004110379A3 A1 adenosine receptor antagonists |
| 03/24/2005 | WO2004093894A3 Use of b7-h3 as an immunoregulatory agent |
| 03/24/2005 | WO2004078756A3 Jnk inhibitors |
| 03/24/2005 | WO2004067554A3 Compositions and methods of tolerizing a primate to an antigen |
| 03/24/2005 | WO2004040302A8 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 03/24/2005 | WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050066378 Transgenic animal comprising gene which induces lymphoproliferation for use as tool in generating autoantibodies for detection and treatment of autoimmune diseases; immunotherapy |
| 03/24/2005 | US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents |
| 03/24/2005 | US20050065153 Antiinflamamtory agents; respiratory system disorders; autoimmune disease |
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors |
| 03/24/2005 | US20050065114 Antitumor, anticancer agents; viricides; bactericides; fungicides; immunology stimulants |
| 03/24/2005 | US20050065112 Antiproliferative agents; low toxicity; psoriasis; antitumor agents; rheumatic arthritis; gastrointestinal disorders; antiinflamamtory agents |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065085 Tissue disorders in response to injuries with administering polypeptidesand antibodies with gene delivery for inflammation such as arthritis |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics |
| 03/24/2005 | US20050064028 Pharmaceutical compositions containing plasma protein |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063978 With a carrier peptide adjuvant that is able to strongly enhance the immune response to a specific co-administered antigen |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |